| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2826.2010.02065.X |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2826.2010.02065.x |
| https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2826.2010.02065.x | ||
| P698 | PubMed publication ID | 20807320 |
| P5875 | ResearchGate publication ID | 227873083 |
| P50 | author | Omar Al-Massadi | Q57014927 |
| Rosa Señarís | Q61162016 | ||
| Luisa Maria Seoane | Q98389771 | ||
| P2093 | author name string | M. L. Trujillo | |
| R. Pasquali | |||
| F. F. Casanueva | |||
| U. Pagotto | |||
| E. Gabellieri | |||
| P2860 | cites work | The endocannabinoid system as an emerging target of pharmacotherapy | Q24648473 |
| Novel cannabinoid receptors | Q24681482 | ||
| The emerging role of the endocannabinoid system in endocrine regulation and energy balance | Q28283398 | ||
| Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion | Q28294318 | ||
| Effect of retinoic acid deficiency on in vivo and in vitro GH responses to GHRH in male rats | Q28320858 | ||
| Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake | Q28572788 | ||
| Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats | Q33319942 | ||
| In vitro effect of delta 9-tetrahydrocannabinol to stimulate somatostatin release and block that of luteinizing hormone-releasing hormone by suppression of the release of prostaglandin E2 | Q33928127 | ||
| SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 | ||
| Evidence for novel cannabinoid receptors | Q34415409 | ||
| Central effects of the somatotropic system | Q35571020 | ||
| The endocannabinoid system and gut-brain signalling. | Q36955435 | ||
| Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials | Q37005419 | ||
| Targeting the endocannabinoid system: to enhance or reduce? | Q37150745 | ||
| Health aspects of cannabis | Q39238279 | ||
| Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity | Q42478605 | ||
| The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats | Q44165158 | ||
| A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. | Q44205907 | ||
| Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection | Q44273304 | ||
| Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. | Q44804052 | ||
| Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. | Q44807365 | ||
| The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance | Q46595047 | ||
| Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex | Q46962183 | ||
| Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level | Q47781778 | ||
| GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections. | Q48227215 | ||
| Sensory stimuli directly acting at the central nervous system regulate gastric ghrelin secretion. an ex vivo organ culture study | Q48401469 | ||
| Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus | Q48404675 | ||
| Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists | Q48444953 | ||
| Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats. | Q48473354 | ||
| Effects of delta 9-THC on growth hormone and ACTH secretion in rats. | Q54065953 | ||
| A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 | Q61776058 | ||
| Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat | Q69833394 | ||
| Differential effects of cannabinoid exposure and stress on plasma prolactin, growth hormone and corticosterone levels in male mice | Q72891822 | ||
| Δ 9 -Tetrahydrocannabinol Increase Plasma Testosterone Concentrations in Mice | Q72896661 | ||
| Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells | Q73145908 | ||
| Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats | Q73191718 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocannabinoid system | Q368952 |
| Cannabinoid receptor antagonist | Q5032579 | ||
| P304 | page(s) | 1127-1136 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Journal of Neuroendocrinology | Q3186929 |
| P1476 | title | Peripheral endocannabinoid system-mediated actions of rimonabant on growth hormone secretion are ghrelin-dependent | |
| Peripheral Endocannabinoid System‐Mediated Actions of Rimonabant on Growth Hormone Secretion are Ghrelin‐Dependent | |||
| P478 | volume | 22 |
| Q91687583 | Cannabinoid CB1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity |
| Q90105011 | Combined Loss of Ghrelin Receptor and Cannabinoid CB1 Receptor in Mice Decreases Survival but does not Additively Reduce Body Weight or Eating |
| Q38599770 | Developmental programming of somatic growth, behavior and endocannabinoid metabolism by variation of early postnatal nutrition in a cross-fostering mouse model |
| Q37015008 | Developmental role for endocannabinoid signaling in regulating glucose metabolism and growth |
| Q35149416 | Endocannabinoid signal in the gut controls dietary fat intake. |
| Q34658658 | Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism |
| Q55059666 | Neuroendocrine Regulation of Growth Hormone Secretion. |
| Q37327465 | The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release |
| Q27301993 | The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake |
| Q38221772 | The role of ghrelin in addiction: a review |
Search more.